Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study.

Autor: Seman ZA; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia.; Centre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Puncak Alam, Selangor, 42300, Malaysia., Ahid F; Centre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Puncak Alam, Selangor, 42300, Malaysia. fadlyahid@uitm.edu.my.; Stem Cell and Regenerative Medicine Research Initiative Group, Universiti Teknologi MARA, Shah Alam, Selangor, 40450, Malaysia. fadlyahid@uitm.edu.my., Kamaluddin NR; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia., Sahid ENM; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia., Esa E; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia., Said SSM; Department of Pathology, Hospital Tunku Azizah, Ministry of Health Malaysia, Kuala Lumpur, Kuala Lumpur, WP, 50300, Malaysia., Azman N; Department of Pathology, Hospital Tunku Azizah, Ministry of Health Malaysia, Kuala Lumpur, Kuala Lumpur, WP, 50300, Malaysia., Mat WKDW; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia., Abdullah J; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia., Ali NA; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia., Khalid MKNM; Inborn Error of Metabolism and Genetic Unit, Metabolic & Cardiovascular Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Nutrition, Shah Alam, Selangor, 40170, Malaysia., Yusoff YM; Hematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, 40170, Malaysia. yuslina.my@moh.gov.my.

Publikováno v: BMC research notes [BMC Res Notes] 2024 Apr 20; Vol. 17 (1), pp. 111. Date of Electronic Publication: 2024 Apr 20.

CRISPR/Cas-Mediated Knock-in of Genetically Encoded Fluorescent Biosensors into the AAVS1 Locus of Human-Induced Pluripotent Stem Cells.

Autor: Stellon D; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia. david.stellon@utas.edu.au., Tran MTN; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia., Talbot J; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia., Chear S; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia., Khalid MKNM; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia., Pébay A; Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC, Australia.; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia., Vickers JC; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia., King AE; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia., Hewitt AW; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia., Cook AL; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS, Australia. anthony.cook@utas.edu.au.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2549, pp. 379-398.

Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.

Autor: Tran MTN; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia., Khalid MKNM; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia., Pébay A; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, Victoria, Australia.; Department of Anatomy and Neuroscience, University of Melbourne, Victoria, Australia., Cook AL; Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS 7000, Australia., Liang HH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Victoria, Australia., Wong RCB; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, Victoria, Australia., Craig JE; Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Australia., Liu GS; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, Victoria, Australia., Hung SS; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, Victoria, Australia., Hewitt AW; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, Victoria, Australia.

Publikováno v: Molecular vision [Mol Vis] 2019 Mar 16; Vol. 25, pp. 174-182. Date of Electronic Publication: 2019 Mar 16 (Print Publication: 2019).